Connection

FARRAH KHERADMAND to Xenograft Model Antitumor Assays

This is a "connection" page, showing publications FARRAH KHERADMAND has written about Xenograft Model Antitumor Assays.
  1. Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft. JCI Insight. 2021 07 08; 6(13).
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.